The capital markets regulator also imposed a penalty of Rs 25 lakh each on both, Shivprasad Pattiya and Alkesh Narware, under “Section 15HA of the SEBI Act, 1992”.

Crispr investors have had a year to put aside so far, with the stock down 25%. Read more on CRSP's execution risks, high ...

Ultra-high yielding ETFs from YieldMax and others have become popular among FIRE fans retiring in their 50s, but there are ...

Around 71% of middle-income Americans are invested in stocks, and they've watched their fortunes rise and fall repeatedly ...

Novo Nordisk rebounds from 2024 lows as GLP-1 supply issues ease, partnerships expand, and valuation turns attractive. Find ...

Like most Vanguard products, it's a low-cost investment vehicle. The Vanguard Total Stock Market ETF has an expense ratio of ...

In all, their investment portfolio pulled in an estimated 54% return in 2024, more than double the S&P 500’s 25% gain — and ...

The recent pullback has some investors wondering whether now is a good time to buy Tesla. Here's a quick comparison of the company's pros and cons.

In the span of only a few years, Nvidia (NVDA -1.14%) has become one of the largest stocks in the world. Indeed, as of this ...

So, what does a product with negligible nicotine, but all the toxicity of a conventional cigarette, offer the consumer?” ...

Peter Berezin is sticking to his bearish views. "At this point, it's hard to make a case to be very optimistic on either the ...

U.S. stocks are drifting on Friday in a quiet return to trading following the Juneteenth holiday. The S&P 500 fell 0.3% in ...